Ildong Holdings corrects disclosure on Idience put option contract, names Ildong Pharmaceutical as buyer
Bitget2026/09/30 09:27- Ildong Holdings filed a corrected disclosure on a put-back option contract tied to Idience’s redeemable convertible preferred share issuance.
- The investor was revised to Ildong Pharmaceutical from the previously disclosed Kiwoom-Yuanta 2019 Scale-up fund group.
- Share subscriptions were updated to 8,000,000 shares at KRW 5,000 each, completed across Nov. 6, 2020, Dec. 14, 2020, Jan. 12, 2021.
- A previously disclosed put-back trigger tied to additional fundraising and pipeline targets by Dec. 31, 2022 was removed.
- The remaining special put-back trigger allows a 50% principal buyback if IPO preliminary review filing missed by Dec. 31, 2023.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin Edges Higher as Treasury Yields, Dollar Ease -- Market Talk
Morgan Stanley is tactically bullish on BHP (BHP.US): Two major copper mine catalysts may ignite the stock price in the next two months
Morgan Stanley maintains an "Overweight" rating on BHP Group, with an "attractive" industry outlook, and sets a target price of AUD 69.00 for its shares listed in Australia.
Bank of England hawkish official: Growth exceeds expectations and employment is resilient, which precisely proves that further rate hikes are necessary.
Megan Greene, a policymaker at the Bank of England, stated that the UK's economic growth surpassing expectations and the resilience of the job market indicate that the Bank of England's efforts to curb inflation are still insufficient.
Crypto prices
More
